… of SARS-CoV-2 seems to be similar to SARS-CoV in some … a convalescent SARS patient
could block the SARS-CoV-2 from … cross-protective epitode between the two viruses. Thus, the …

… manifestations of SARSCoV-2 infection. Patients with B-cell-depleted lymphoma with
protracted SARS-CoV-2 infection may be excellent candidates for passive transfer of immunity by …

… antibody responses in convalescent patients, and documented cases of SARS-CoV-… We
discuss our understanding of immunity and immune memory following SARS-CoV-2 infection. …

… Moreover, the detection of T cells that are specific for the original SARS-CoV nucleoprotein
in patients years after infection highlights the potential role of T cells in generating long-…

… patient with COVID-19 was associated with the emergence of new SARS-CoV-2 variant
populations in that patient, … (A) Within an immunocompetent individual, SARS-CoV-2 infection …

… This study reveals several insights into the antibody response to SARS-CoV-2 infection
with … in COVID-19 patients. The central role of inflammation in the pathogenesis of severe …

… COVID-19 patients, from which we evaluate neutralizing antibody titers against SARS-CoV-2 …
to both BNT162b2 vaccination and natural infection. We find that vaccinated serum is less …

… adaptive immunological features of convalescent COVID-19 patients but also provide
information on the development vaccine and therapeutic agents against SARS-CoV-2 infection. …

… viable SARS-CoV from the urine of a convalescent patient has not been reported previously.
Our isolation of living SARS-CoV from the stool specimens of convalescent SARS patients …

… titres reduced significantly among 27 convalescent patients around six weeks following
disease … in the convalescent phase, co-existence of SARS-CoV-2 specific IgG and detectable …